Novabay Pharmaceuticals Inc (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,455 | 5,748 | 7,670 | -7,223 | -6,011 |
| Depreciation Amortization | 681 | 3 | 2 | 40 | 24 |
| Accounts receivable | -368 | N/A | N/A | 291 | 243 |
| Other Working Capital | -422 | 245 | 1,387 | -595 | -596 |
| Other Operating Activity | -10,501 | -10,311 | -10,383 | 2,304 | 519 |
| Operating Cash Flow | $-6,155 | $-4,315 | $-1,324 | $-5,183 | $-5,821 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -6 | -2 |
| Net Acquisitions | N/A | N/A | N/A | 1,070 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $1,064 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 500 | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,990 | -1,991 |
| Common Stock Issued | N/A | 614 | 614 | 3,105 | 2,858 |
| Common Stock Repurchased | -1,138 | -1,989 | -1,815 | N/A | 247 |
| Dividend Paid | -4,815 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 2,752 | -507 | -507 | -115 | -115 |
| Financing Cash Flow | $-3,201 | $-1,882 | $-1,708 | $1,500 | $999 |
| Beginning Cash Position | 907 | 907 | 907 | 3,606 | 3,606 |
| End Cash Position | 2,702 | 5,821 | 8,944 | 907 | 1,253 |
| Net Cash Flow | $1,795 | $4,914 | $8,037 | $-2,699 | $-2,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,155 | -4,315 | -1,324 | -5,183 | -5,821 |
| Capital Expenditure | N/A | N/A | N/A | -6 | -2 |
| Free Cash Flow | -6,155 | -4,315 | -1,324 | -5,189 | -5,823 |